Measuring Anatomical Outcomes of Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema With Artificial Intelligence-A Step Toward Individualized Medicine.

Rohowetz, Landon J; Sabates, Nelson R; Koulen, Peter

Rohowetz, Landon J; Sabates, Nelson R; Koulen, Peter.

Affiliation

Rohowetz LJ; Vision Research Center, Department of Ophthalmology, School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri.
Sabates NR; Vision Research Center, Department of Ophthalmology, School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri.
Koulen P; Vision Research Center, Department of Ophthalmology, School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri.

JAMA Ophthalmol ; 138(9): 953-954, 2020 09 01.

Article in En | MEDLINE | ID: mdl-32722767

Subject(s)

Deep Learning; Diabetes Mellitus; Diabetic Retinopathy; Macular Edema; Artificial Intelligence; Diabetic Retinopathy/drug therapy; Humans; Macular Edema/drug therapy; Precision Medicine; Ranibizumab/therapeutic use; Visual Acuity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Macular Edema / Diabetes Mellitus / Diabetic Retinopathy / Deep Learning Type of study: Prognostic_studies Limits: Humans Language: En Journal: JAMA Ophthalmol Year: 2020 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google